Loading...
Please wait, while we are loading the content...
Similar Documents
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction
| Content Provider | Scilit |
|---|---|
| Author | Rawstron, Andy C. Gregory, Walter M. Tute, Ruth M. De Davies, Faith Bell, Sue E. Drayson, Mark Cook, Gordon Jackson, Graham H. Morgan, Gareth J. Child, J. Anthony Owen, Roger G. |
| Copyright Year | 2015 |
| Description | Key Points The level of MRD quantified by flow cytometry is more informative than a 0.01% threshold and independently predicts OS. There was approximately 1 year survival benefit per log depletion. A lower cut point for predicting improved outcome was not reached. |
| Related Links | http://www.bloodjournal.org/content/bloodjournal/125/12/1932.full.pdf |
| Ending Page | 1935 |
| Page Count | 4 |
| Starting Page | 1932 |
| DOI | 10.1182/blood-2014-07-590166 |
| Journal | Blood |
| Issue Number | 12 |
| Volume Number | 125 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2015-03-19 |
| Access Restriction | Open |
| Subject Keyword | Hematology Flow Cytometry Independent Prediction Benefit Per Log Myeloma Mrd Level Minimal Residual Disease Survival Journal: Blood (Vol- 121, Issue- 12) |
| Content Type | Text |
| Resource Type | Article |
